BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
Japan flag Japan · Delayed Price · Currency is JPY
39.00
0.00 (0.00%)
May 9, 2025, 3:30 PM JST

TYO:4594 Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2018 FY 2017
Period Ending
Dec '18 Mar '18 Mar '17
Net Income
--1,573-1,116
Depreciation & Amortization
-7341
Other Operating Activities
--313
Change in Accounts Receivable
--2251
Change in Inventory
-14-6
Change in Accounts Payable
--13-41
Change in Other Net Operating Assets
--67-9
Operating Cash Flow
--1,591-1,067
Capital Expenditures
--108-97
Cash Acquisitions
--7
Sale (Purchase) of Intangibles
--3-6
Investing Cash Flow
--111-96
Issuance of Common Stock
-3,2813,559
Financing Cash Flow
-3,2813,559
Miscellaneous Cash Flow Adjustments
--1-1
Net Cash Flow
-1,5782,395
Free Cash Flow
--1,699-1,164
Free Cash Flow Margin
--479.94%-220.04%
Free Cash Flow Per Share
--44.44-34.22
Cash Income Tax Paid
-32
Levered Free Cash Flow
--1,029-
Unlevered Free Cash Flow
--1,029-
Change in Net Working Capital
7915-
Updated Feb 14, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.